Martin Health System Unveils Xenex Germ-Zapping Robot™ more

Jesuit High School Alumnus Donates Xenex Germ-Zapping Robot to His Alma Mater more

BiO2 Medical Announces Successful Completion of the Angel® Catheter Pivotal Clinical Trial more

Xenex Awarded Premier, Inc. Group Purchasing Contract to Offer Germ-Zapping Robot™ Room Disinfection Technology to Premier Member Hospitals more

SA bioscience companies strike new deal to expand scope of stem cell research more

TFS Corporation share price flat despite soaring earnings more

TFS Corporation doubles quarterly profit more

Innovation makes money grow on trees more

Xenex Germ-Zapping Robot™ Destroys Ebola Virus & Anthrax Spores in New Study Performed at Texas Biomed Biosafety Level 4 Lab more

Indian sandalwood oil producer ramps up production to supply new markets more

Cytocentrics Inc. wins Innovator Award at recent event more

Key Opinion Leader (KOL) Calls for New Standard to Close Port-Site Hernias in Lap and Robotic Surgeries more

Surgical Site Infections Decrease 100% after Trinity Medical Center Implements Infection Control Bundle more

Court Order Requires Tru-D to Cease False and Misleading Statements more

Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration more

San Antonio biotech firm CEO is heading west more

Sandalwood grower smells a fortune more

Explore the UV LED market that is expected to reach USD 369.58 million by 2020 more

Ten Life Sciences Companies to Watch in Central Texas more

San Antonio’s Xenex signs national contract with HealthTrust more

Xenex Signs Agreement with HealthTrust; Germ-Zapping Robots™ Added to the HealthTrust Portfolio more

Benzac® Intensive Spot Treatment Named Best Acne Treatment of 2015 by HEALTH Magazine more

neoSurgical® Reports Commercial Milestone of 2000 US Procedures more

Launch of latest hyaluronic acid based filler range more

Galderma Laboratories Announces the Nationwide Availability of Benzac® more

BioMed SA Celebrates 10th Anniversary more

TFS completes US pharma acquisition more

Finally, Good News for Anyone Looking for a Gentle Acne Treatment more

4th Peer-Reviewed Study to Credit Xenex Germ-Zapping Robots for Infection Rate Decrease more

A pair of biotech VCs take aim at raising SA’s status more

BiO2 Medical raises $4M for device that prevents embolism more

How SA landed Cytocentrics more

Sandalwood firm sticks to forecasts more

Two New Studies Show Decrease in Hospital Acquired Infections after Xenex Germ-Zapping Robots Used for Room Disinfection more

Xenex Offers Industry’s First HAI Reduction Guarantee; Multiple Hospitals Report Decrease in Infection Rates When Using Xenex Germ-Zapping Robots for Room Disinfection more

Xenex to expand sales of ‘germ-zapping robots’ to more European nations more

West Australian Indian sandalwood oil producer purchases American drug companies more

Sandlewood grower to buy US-based pharmaceutical firms more

Cytocentrics has big plans for San Antonio more

TFS Corporation Limited jumps on acquisitions: What you need to know more

Australian firm acquires multiple San Antonio bioscience companies; Deal could be worth $270 million more

TFS To Acquire ViroXis And Santalis Pharma - Quick Facts more

DNAtrix Collaborators Present Data on a Novel Oncolytic Adenovirus Expressing OX40 Ligand that Promotes Antitumor Immunity more

San Antonio expected to become bigger global research player as result of Cytocentrics deal more

Cytocentrics Wins $1 Million Incentive and Warm Welcome to San Antonio more

San Antonio approves major incentive deal to lure German biotech firm more

German Biosciences Company Relocating Headquarters to San Antonio more

Cytocentrics looking to relocate HQ to San Antonio, create 300 jobs more

Cytocentrics CEO: Biotech company passed up bigger financial offers to move to San Antonio more

Milwaukee VA center cleared to use germ-zapping robots more

GAO Affirms VA Contract for Mercury-Free UV Disinfection System, Milwaukee VA Hospital Orders Xenex Full-Spectrum™ Germ-Zapping Robots™ more

Pivotal Investigation of BiO2 Medical's Angel Catheter Exceeds Enrollment Expectations more

Alcyone Lifesciences and DNAtrix Enter Clinical Collaboration for Brain Cancer more

Here’s why these 4 companies are soaring higher today more

Harvard gets wood more

2 Works for You helps teen diagnosed with brain cancer denied access to experimental treatment more

Harvard University sees the good oil in NT sandalwood plantation more

San Antonio bioscience companies to team up on critical research more

Germ-zapping R2-D2 look-alike works at Renown more

Are TFS Corporation Limited shares an absolute bargain? more

Med tech start-up exits Bank of Ireland Seed Fund with US$21m valuation more

Galway-based NeoSurgical exits Kernel Capital more

Xenex sells Germ-Zapping robot to Iowa nonprofit hospital more

Broadlawns Employs Xenex Robot to Eradicate Germs more

Benzac® Acne Solutions Premieres Its First-Ever “Insta-Dramedy” Webseries more

Sandalwood grower enlists F1 star more

StemBioSys closes $8m in funding to help launch its stem cell culture system more

Irish start-up neoSurgical has just signed an exclusive distribution deal for the US market. But, as founder and CEO Barry Russell explains, it has taken persistence and courage to get the company this far more

Xenex exporting hospital-cleaning robots to Europe more

Xenex Germ-Zapping Robots Arrive in Spain; Clece Chooses Xenex for Hospital Disinfection more

Takes $8M to Build Homes For Stem Cells more

San Antonio biomedical company StemBioSys scores major funding more

Lexington Fire Department chosen to conduct trial on new EMS Equipment more

Xenex Rebuts Clorox Attack Following NAD Press Release more

San Antonio’s Xenex files lawsuit against Cloroxn more

Lexington Fire Dept. Among First In Kentucky Testing New Device more

Here’s why today is a good day to buy TFS Corporation Limited shares more

Over-the-counter (OTC) remedies rescue consumers from skin and health issues that are—at the time—more pressing than fine lines and wrinkles more

Germ-zapping Dalek-like robots trialed at King’s Lynn’s Queen Elizabeth Hospital to reduce the spread of infection more

Seven Women Run Tech Startups in San Antonio to Watch more

UV light from robots disinfects hospital rooms more

TFS rises on upgraded guidance more

Biological assets boost valuation for TFS more

NPSF Patient Safety Coalition Welcomes Xenex more

UV Disinfection Equipment Market is Expected to Reach $2.8 Billion by 2020 – Allied Market Research more

Scent of success more

BiO2 Medical Begins Enrollment for the Pivotal Investigation of the Angel® Catheter more

Baptist Health's new germ-zapping robots use untraviolet light as a disinfectant more

Baptist Health adds "cleaning robots" more

The Only Full Spectrum™ Pulsed Xenon UV Disinfection System more

Benzac® Acne Solutions Launches in the US more

State of health care: Xenex CEO says company is winning war against deadly infections more

The Health Cell to present event focusing on San Antonio’s health care and biosciences sector more

San Antonio bioscience company Xenex secures major funding

Serial entrepreneurs are those who take on the risks of building a company good enough to be sold to an older, larger company and taking the proceeds to start another company.

Success breeds success, after all.

Just as important for that to happen are the company executives hired by the entrepreneurs.
An example of such an executive in San Antonio’s health care and medical devices sector is Gabriele Niederauer, now CEO and president of Bluegrass Vascular Technologies Inc.

Niederauer’s story is special because her commitment to San Antonio is one reason why Bluegrass Vascular Technologies moved its base here from Kentucky. It’s an example of San Antonio executive expertise helping bring a company here instead of companies leaving the city to find executive talent elsewhere.

Bluegrass Vascular Technologies, founded in 2010 by Dr. John Gurley, has developed a product called the Surfacer, which provides an alternative way to access veins for dialysis, nutrition and chemotherapy when the main veins are obstructed by blood clots or scar tissue.

The company is a spinoff from Therix Medical in Lexington, Kentucky, an incubator of Kentucky Technology Inc.

Niederauer previously had worked at several San Antonio biotechnology companies: OsteoBiologics Inc., C2M Medical Inc. and ENTrigue Surgical. At ENTrigue Surgical, which makes sinus surgery devices, Niederauer was senior vice president for technology and development under CEO and serial entrepreneur Fred Dinger.

She has emerged as a leader in San Antonio’s health care and medical device industry as a founder of both Medical Industry Organization of San Antonio, which encourages startup companies to help each other in expertise and shared resources, and The Health Cell, which promotes professional development in San Antonio’s health sector.

In July 2013, Austin-based ArthroCare Corp. announced it was buying ENTrigue Surgical for $45 million, a big win for ENTrigue Surgical investors, mainly Prism VentureWorks, the Vertical Group and San Antonio’s Targeted Technology Fund. Niederauer had a small equity stake, too, in ENTrigue Surgical.

She stayed on at ENTrigue Surgical for about a year until an even bigger company, London-based Smith & Nephew, acquired Austin’s ArthroCare.

Smith & Nephew moved to consolidate the ENTrigue Surgical unit into its Austin operations, but Niederauer left the company, preferring to stay in San Antonio.

Upon leaving Smith & Nephew/ArthroCare, Niederauer became CEO and president of Bluegrass Vascular Technologies in September. A significant Bluegrass investor is San Antonio’s Targeted Technology Fund, headed by Paul Costella. Niederauer, of course, already had experience working with the venture capital fund.

“I was passionate about wanting to stay in San Antonio,” Niederauer said. Bluegrass “was a good fit for me . . . I felt I could be a good asset for Bluegrass.”

Another reason for coming to San Antonio: Bluegrass had grant money from the Texas Department of Agriculture’s Jobs for Texas program. The grant initially had been received and dispersed by the Targeted Technology Fund. The grant requires companies to be based in Texas.

Dinger himself publicly told the biotechnology community about the necessity of finding experienced executives in August 2013, soon after ENTrigue was sold, when addressing an Emerging Venture Pipeline luncheon. Startups need to begin with a great core team of executives, Dinger said. An “A” team with a “C” technology is better than a “C” team with “A” technology, is the way Dinger put it.

Niederauer said the difficult part about switching jobs, even within health care, is learning the different industries. She has gone from sport medicine to sinus surgical devices to vascular tools.
“But the commonality is that in no matter what industry, you have to take the same steps to get products to market,” Niederauer said. She certainly has learned that at her previous companies.
Some startup medical device companies are sold to established companies even before selling products to the marketplace, Niederauer acknowledged.

“But, more and more, companies want to see doctors buying and using the products,”

Niederauer said. “That exposure on the market can tell acquirers how good the product is.”

Bluegrass expects to begin sales of its Surfacer product in Europe by the third quarter of this year.

The trend is clear: As San Antonio biotechnology and medical device startups are sold, entrepreneurs and executives are valuable assets to attract new investments to the city’s biotechnology sector.

Source: http://www.expressnews.com

6th February 2015 back

Xenex’s latest funding exceeds expectations, expands international opportunities more

San Antonio bioscience company Xenex secures major funding more

Germ-Zapping Robot Makes House Call for Texas Baby more

Hospitals name their disinfecting robots to add personality more

The robot will clean up now: More hospitals buying automated systems to reduce infections more

New Study Shows Pulsed Xenon UV Light Effective in Reducing C. diff, MRSA and VRE in the Hospital Environment more

Forecast: Three San Antonio biomedical companies to watch in 2015 more

Here’s why these 4 stocks are soaring higher today more

Sandalwood the good oil for US funds more

Oil Investment Could Put A Smile On The Faces Of Harvard Students more

Harvard takes stake in TFS more

Aromatherapy at home can be easy more

TFS up on US acne product launch more

BiO2 Medical Receives IDE Approval to Initiate Pivotal Investigation of the Angel® Catheter more

StemBioSys Inc. to Present at Biotech Showcase™ 2015 more

Galderma Laboratories Launches Its First Over-the-Counter Acne Regimen, Benzac® Acne Solutions more